| 1/2 | US=58 / Cāncer Le XF, Bast Junior RC. p27Kip1 as a biomark and target for treatment of cancer. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 215-33. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. P27KIP1; CICLO CELULAR; SUPRESSOR DE TUMOR; TERAPIA ALVO; TRASTUZUMAB |
| 2/2 | US=84 / Biol/Mol Gold LI, Lecanda J. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of cell cycle regulation by TGF-B disabled in cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 213-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. P27KIP1; CKS1; SKP2; CANCRO ENDOMETRIAL; UBIQUITINA-PROTEASSOMA |